KATHRYN FREEMAN: Open Payments
NPI 1740982123 · LEXINGTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$342 in 16 payments from 6 companies in 2025. Trend: 2023 $344 · 2024 $751 · 2025 $342
Food & beverage: $342
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $202 |
| Xeris Pharmaceuticals, Inc. | 1 | $50 |
| Stryker Corporation | 1 | $39 |
| Corcept Therapeutics | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| PFIZER INC. | 1 | $16 |
Products named: VRAYLAR, KEVEYIS, QULIPTA, FLOWTRIEVER CATHETER, S, UBRELVY, Korlym, PREVNAR 20.
Industry payments across SC — which companies pay providers there.
